915063

Sumitomo Pharma America, Inc. — FEI 1222021

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
January 23, 2015
Fiscal Year
2015
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Marlborough, MA (United States)

Additional Details

Postmarket Adverse Drug Experience (PADE)

Citations

IDCFRDescription
673221 CFR 314.80(c)(1)(i)Late submission of 15-day report